Skip to Main Content

Paper Details

Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell Lung Cancer.
Clin Cancer Res
3
2023
/, ARID2, ATM, ATM Mutations, ATM mutations, ATM-wild-type, ATMMUT, ATMMUT) NSCLC, ATMWT, DNA damage and repair gene, EGFR mutations, KRAS, NSCLC, NSCLC tumors, NSCLCs, Non-Small Cell Lung Cancer, PD-(L)1, Patients, STK11, TP53, non, non-small cell lung cancer, patients, squamous histology, tumor, tumor-infiltrating immune cell subsets, tumors
Author NameAffiliation
Andrew D CherniackDana-Farber Cancer Institute, Broad Institute of Harvard and Massachusetts Institute of Technology (MIT)
Andrew D CherniackDana-Farber Cancer Institute, Broad Institute of Harvard and Massachusetts Institute of Technology (MIT)
Daniel R GomezMemorial Sloan Kettering Cancer Center
Chaitanya BandlamudiMemorial Sloan Kettering Cancer Center
Marc LadanyiMemorial Sloan Kettering Cancer Center
Pasi A J??nneLowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School
  • 1 - 6

Datasets

Release 1.2